Archives
-
SNORA73 and the Emerging Biology of snoRNA
2026-10-07
A 2025 Cell Research highlight describes how snoKARR-seq revealed snoRNA interactions beyond canonical ribosomal and spliceosomal RNA modification. The reported SNORA73–mRNA–7SL RNA interaction connects snoRNA biology with nascent protein targeting to the endoplasmic reticulum, while also highlighting important limits in evidence and transferability.
-
Balsalazide Disodium in Colitis Research
2026-10-06
Balsalazide disodium is a colon-targeted 5-aminosalicylic acid prodrug studied in inflammatory bowel disease research. This overview examines the reported mouse radiotracer study of radioiodinated balsalazide, including its biodistribution findings, conceptual imaging applications, evidence strength, and translational limitations. It also distinguishes peer-reviewed findings from supplier descriptions and clarifies why animal uptake data do not establish human diagnostic performance, treatment efficacy, or pathway-specific activity.
-
Potassium Phosphate Monobasic in Nucleic Acid Research
2026-10-06
Potassium phosphate monobasic, or KH2PO4, is widely recognized as an aqueous phosphate reagent for pH control in biochemical systems. This overview explains its conceptual relevance to biological assays and nucleic acid lipid nanoparticle research while distinguishing supplier information from published evidence. It also examines what current drying literature supports—and what remains unproven—about using phosphate-containing environments in mRNA-LNP stability studies.
-
RNASEH1-AS1 in Hepatocellular Carcinoma
2026-10-05
A 2024 study integrated TCGA-based analysis, prognostic modeling, cell-based validation, and mechanistic investigation to characterize RNASEH1-AS1 in hepatocellular carcinoma. The findings support RNASEH1-AS1 as a candidate biomarker and oncogenic lncRNA, while also highlighting the need for independent clinical validation and deeper mechanistic studies.
-
EZ Cap™ Firefly Luciferase mRNA Overview
2026-10-05
APExBIO describes EZ Cap™ Firefly Luciferase mRNA as an in vitro-transcribed firefly luciferase reporter transcript with a Cap 1 analog and an approximately 100-nucleotide poly(A) tail. No matched paper evidence was provided, so product-performance claims remain supplier-reported.
-
Fluorouracil and the New Logic of Tumor Heterogeneity
2026-10-04
Fluorouracil remains a powerful model for studying how nucleotide metabolism, inhibition of DNA replication, and tumor evolution intersect. This thought-leadership analysis connects the mechanism of 5-Fluorouracil with findings from colorectal cancer metastasis research, while defining the evidence boundaries that translational teams should respect.
-
EZ Cap™ Firefly Luciferase mRNA Workflows
2026-10-02
Build sensitive gene regulation, translation, and imaging assays around a Cap1-capped, polyadenylated firefly luciferase transcript. This practical guide connects mRNA handling, controlled delivery, temperature-aware assay design, and troubleshooting for reproducible research readouts.
-
RNA Labeling as a Window into m6A Biology
2026-10-01
Mechanistic studies increasingly connect RNA modification with protein post-translational states, disease biology, and assay design. This thought-leadership article explains how biotinylated T7 transcripts can support translational investigation of the METTL14–SMN axis while outlining controls, competitive considerations, and responsible interpretation.
-
Sodium chloride B7288: Buffer Preparation and QC
2026-10-01
Sodium chloride B7288 is an inorganic salt for setting ionic strength and supporting osmotic balance in aqueous buffers, biochemical assays, and selected cell culture media workflows. It should be dissolved in water and used promptly; it is not a pH buffer, a DMSO or ethanol stock material, or a substitute for sterility-qualified reagents.
-
SU6656 Src Tyrosine Kinases Inhibitor Guide
2026-09-30
SU6656 is a Src tyrosine kinases inhibitor used to study PDGF/Src signaling, megakaryocyte polyploidization, and tumor vascular responses to irradiation. Product data support its DMSO formulation and storage requirements, while the 2026 hiPSC platelet study provides a benchmark for small-molecule optimization without establishing SU6656 as the cause of its reported yield.
-
METTL14–SMN Signaling in m6A Homeostasis
2026-09-30
The reference study identifies SMN as an interaction partner of the m6A methyltransferase component METTL14 and shows that this association depends on arginine methylation. Its findings connect SMN Tudor-domain mutations in spinal muscular atrophy with altered m6A deposition, impaired DNA-repair gene expression, and sensitivity to DNA damage, while a methylation-deficient Mettl14 mouse model reveals developmental and hematopoietic consequences.
-
D-Luciferin Potassium Salt for Bioluminescence Imaging
2026-09-29
D-Luciferin potassium salt is a water-soluble firefly luciferase substrate for in vivo bioluminescence imaging and in vitro reporter assays. Its ATP-, magnesium-, and oxygen-dependent light reaction supports non-invasive tracking, but signal interpretation depends on reporter expression, substrate delivery, tissue attenuation, and assay controls.
-
ddhCTP: A Mechanism-First Antiviral Assay Guide
2026-09-29
ddhCTP is a biologically generated nucleotide analog that can terminate viral RNA synthesis by selected RNA-dependent RNA polymerases. This guide presents a mechanism-first framework for using ddhCTP in flavivirus studies, HEK293T cell antiviral assays, and experiments distinguishing polymerase inhibition from broader viperin activity.
-
Illuminating GBM Translation with D-Luciferin
2026-09-28
A translational framework for using D-Luciferin potassium salt to quantify luciferase-labeled glioblastoma models, interpret biomaterial responses, and connect longitudinal bioluminescence imaging with mechanistic validation.
-
From RUNX2 to Reliable Samples: Translational Rigor
2026-09-28
A translational perspective on connecting osteoblast mechanism studies with disciplined blood sample preparation. Learn what the trelagliptin–RUNX2 findings establish, where their limits remain, and how selective erythrocyte removal can support separate downstream analyses.